Table 4. Cost and Cost Effectiveness by Intervention groups over two years in US $.

Characteristic	HHE and Trained GP (n = 332)	HHE Only (n = 348)	Trained GP Only (n = 335)	No Intervention (n = 326)	*p- value
Patient level costs†
On GP Consultations	45.0	32.4	29.5	36.0	0.902
On Medication	116.0	81.3	108.6	98.7	0.862
On Laboratory	28.2	13.6	27.7	26.4	0.303
Total Expenses on Health Care	189.1	127.3	165.8	161.1	0.161
On Fruits & Vegetables	103.7	101.2	117.0	99.8	0.295
Total Patient costs on health‡	296.5	219.8	278.1	252.1	0.129
Productivity loss @ USD 5.72/-	195.4	166.7	258.4	205.3	0.177
Intervention Cost	8.0	6.7	1.3	-
Mean SBP Effect (95% C.I)	10.8 (8.9 to 12.8)	5.6 (3.7 to 7.5)	5.6 (3.7 to 7.4)	5.8 (3.9 to 7.7)
Total Cost§	499.9	393.2	537.8	457.4
ICER∥	23 (6 to 99)	Dominated (dominated to 714)	201 (dominated to 790)	-
5% Discounting
Mean SBP Effect (95% C.I)	9.8	5.1	5.1	5.3
Total Cost §	464.9	365.7	500.2	425.4
ICER∥	23 (7 to 101)	Dominated (dominated to 730)	206 (dominated to 807)	-

^*p-values are calculated based on raw data

^†Patient level costs computed based on average of inflated baseline and final visit.

^‡Total patient costs on health included GP consultation, medication, laboratory, fruit and vegetable expenses.

^§Total cost included total patients costs on health, productivity loss and intervention cost

^∥Incremental Cost-Effectiveness Ratio calculated based upon boot strapping

All expenses are expressed in US $, valued of exchanges rate based on July 2007 (1 USD=Pak Rs 61)